Serum Endocan and Preoperative Systemic Inflammatory Markers in Patients with Epilepsy.

[1]  I. Koyuncu,et al.  Comparison of cytokines and prooxidants/antioxidants markers among adults with refractory versus well-controlled epilepsy: A cross-sectional study , 2018, Seizure.

[2]  S. Yeni,et al.  Effect of Temporal Neocortical Pathology on Seizure Freeness in Adult Patients with Temporal Lobe Epilepsy. , 2018, World neurosurgery.

[3]  N. Çomunoğlu,et al.  Dysembryoplastic neuroepithelial tumours: clinical, radiological, pathological features and outcome , 2018, British journal of neurosurgery.

[4]  A. Musto,et al.  The role of inflammation in the development of epilepsy , 2018, Journal of Neuroinflammation.

[5]  J. Łuszczki,et al.  Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies , 2018, Pharmacological reports : PR.

[6]  A. Becker,et al.  Review: Animal models of acquired epilepsy: insights into mechanisms of human epileptogenesis , 2018, Neuropathology and applied neurobiology.

[7]  M. Cankurtaran,et al.  Higher Serum Endocan Level Is Associated with Alzheimer Disease , 2018, Dementia and Geriatric Cognitive Disorders.

[8]  B. Silva,et al.  Brain expression of inflammatory mediators in Mesial Temporal Lobe Epilepsy patients , 2017, Journal of Neuroimmunology.

[9]  Ming Chen,et al.  Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study. , 2017, Journal of neurosurgery.

[10]  S. Yeni,et al.  Tissue Expressions of Soluble Human Epoxide Hydrolase-2 Enzyme in Patients with Temporal Lobe Epilepsy. , 2017, World neurosurgery.

[11]  A. Gunduz,et al.  Comparison of clinical features and surgical outcome in focal cortical dysplasia type 1 and type 2 , 2017, Epilepsy Research.

[12]  S. Ateş,et al.  Serum endocan levels before and after surgery on low-grade gliomas , 2017, Surgical neurology international.

[13]  R. Ransohoff,et al.  Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus , 2016, Proceedings of the National Academy of Sciences.

[14]  P. Atukeren,et al.  Expressions of Endocan in Patients with Meningiomas and Gliomas , 2016, Disease markers.

[15]  Raquel R. Roth,et al.  Does angiogenesis play a role in the establishment of mesial temporal lobe epilepsy? , 2016, International Journal of Developmental Neuroscience.

[16]  M. Braddock,et al.  Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer , 2016, Oncotarget.

[17]  F. Cendes,et al.  Peripheral leukocyte profile in people with temporal lobe epilepsy reflects the associated proinflammatory state , 2016, Brain, Behavior, and Immunity.

[18]  D. Mikhailidis,et al.  Endocan: A novel inflammatory indicator in cardiovascular disease? , 2015, Atherosclerosis.

[19]  Qingchang Li,et al.  Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma , 2015, BMC Cancer.

[20]  P. Pickkers,et al.  Inflammation-Induced Increases in Plasma Endocan Levels are Associated With Endothelial Dysfunction in Humans in vivo , 2015, Shock.

[21]  Wonhwa Lee,et al.  Endocan Elicits Severe Vascular Inflammatory Responses In Vitro and In Vivo , 2014, Journal of cellular physiology.

[22]  A. Morita,et al.  Endocan, a new invasion and angiogenesis marker of pituitary adenomas , 2014, Journal of Neuro-Oncology.

[23]  S. Chevret,et al.  Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[24]  M. Delehedde,et al.  Endocan in Cancers: A Lesson from a Circulating Dermatan Sulfate Proteoglycan , 2013, International journal of cell biology.

[25]  V. Rigau,et al.  Why and how to target angiogenesis in focal epilepsies , 2012, Epilepsia.

[26]  E. Felip,et al.  Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer , 2012, Clinical and Translational Oncology.

[27]  Y. Wang,et al.  Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin , 2011, Molecular Biology Reports.

[28]  V. Amassian,et al.  Lymphocyte infiltration of neocortex and hippocampus after a single brief seizure in mice , 2010, Brain, Behavior, and Immunity.

[29]  Xiang Ding,et al.  Endocan Expression Correlated with Poor Survival in Human Hepatocellular Carcinoma , 2009, Digestive Diseases and Sciences.

[30]  W. Aird,et al.  Vascular endocan is preferentially expressed in tumor endothelium. , 2006, Microvascular research.

[31]  E. Oby,et al.  Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations , 2006, Neuroscience.

[32]  J. Pugin,et al.  Endocan, a new endothelial marker in human sepsis* , 2006, Critical care medicine.

[33]  P. Gloor.  The Temporal Lobe and Limbic System , 1997 .

[34]  Jerome Engel,et al.  Introduction to temporal lobe epilepsy , 1996, Epilepsy Research.

[35]  J. Tavernier,et al.  ESM-1 Is a Novel Human Endothelial Cell-specific Molecule Expressed in Lung and Regulated by Cytokines* , 1996, The Journal of Biological Chemistry.

[36]  S. Yeni,et al.  Preoperative Systemic Inflammatory Markers in Different Brain Pathologies: An Analysis of 140 Patients. , 2018, Turkish neurosurgery.

[37]  Tallie Z. Baram,et al.  The role of inflammation in epilepsy , 2011, Nature Reviews Neurology.

[38]  H. Scharfman,et al.  Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword. , 2004, Advances in experimental medicine and biology.